Search by Drug Name or NDC

    NDC 73153-0900-01 BREYANZI Details

    BREYANZI

    BREYANZI is a KIT in the CELLULAR THERAPY category. It is labeled and distributed by Juno Therapeutics, Inc.. The primary component is .

    Product Information

    NDC 73153-0900
    Product ID 73153-900_1107bed2-4fa1-4953-b193-7d882c61f897
    Associated GPIs 21651050401820
    GCN Sequence Number 081910
    GCN Sequence Number Description lisocabtagene maraleucel VIAL 70X 10EXP6 INTRAVEN
    HIC3 V35
    HIC3 Description ANTINEOPLASTIC - CAR-T CELL IMMUNOTHERAPY
    GCN 49174
    HICL Sequence Number 047106
    HICL Sequence Number Description LISOCABTAGENE MARALEUCEL
    Brand/Generic Brand
    Proprietary Name BREYANZI
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lisocabtagene maraleucel
    Product Type CELLULAR THERAPY
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Juno Therapeutics, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125714
    Listing Certified Through 2024-12-31

    Package

    NDC 73153-0900-01 (73153090001)

    NDC Package Code 73153-900-01
    Billing NDC 73153090001
    Package 1 KIT in 1 CARTON (73153-900-01) * 5 mL in 1 VIAL, SINGLE-DOSE (73153-902-04) * 5 mL in 1 VIAL, SINGLE-DOSE (73153-901-08)
    Marketing Start Date 2021-02-05
    NDC Exclude Flag N
    Pricing Information N/A